Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene - Wikidata - awgldk - TriplyDB

Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene

Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene

http://www.wikidata.org/entity/Q34045325

about

Candida albicans Biofilms and Human Disease Mechanisms of Candida biofilm drug resistance Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida Post-transcriptional gene regulation in the biology and virulence of Candida albicans Development of a high-throughput Candida albicans biofilm chip A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance Transcriptional profiling of a yeast colony provides new insight into the heterogeneity of multicellular fungal communities An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus Biofilms Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.The Candida albicans Biofilm Matrix: Composition, Structure and Function A quantitative real-time RT-PCR assay for mature C. albicans biofilms.Novel entries in a fungal biofilm matrix encyclopedia In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis.Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights.Fungal biofilms, drug resistance, and recurrent infection Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.Community participation in biofilm matrix assembly and function Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.An expanded regulatory network temporally controls Candida albicans biofilm formation.Fungal biofilm resistance.Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions.Topological and mutational analysis of Saccharomyces cerevisiae Fks1 Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.Current perspectives on echinocandin class drugs.Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo.Recent insights into Candida albicans biofilm resistance mechanisms Future directions for anti-biofilm therapeutics targeting Candida.Mechanisms of Antifungal Drug Resistance.Combinatorial drug approaches to tackle Candida albicans biofilms.Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Biofilm formation in Candida glabrata: What have we learnt from functional genomics approaches?

P2860

Q26778729-0799840B-129E-4E45-A455-5F72DF5D7A1E Q26827521-58443B2F-82BA-4BBE-A5FE-4C86D65884D1 Q26861656-C3D9F4AB-BA08-461A-87E2-B842A21F6661 Q27026751-94A2505D-2A64-450A-833C-835664A072C0 Q28076944-FE851D27-F69D-413A-9A04-5ABC61A18C77 Q28477874-1C2606E3-7413-4CC7-9F27-2564AB3DC21A Q28481813-CC2F1155-FAA6-49E3-B8B7-CFC2F3EA74A1 Q28484115-E9C1E9C6-CF19-4D8A-B660-7F16CC4C527D Q28552679-DD28A2C8-CF35-4CF5-A49F-FCCF78EDECF5 Q28818603-616FFDD4-9A1B-4F53-A53F-39E0C85C6743 Q33603993-2489A42C-21A0-4EDF-88B1-E62D6568A32D Q33684840-B9C644C3-B4A6-4E26-AF7A-58B17F8EEF15 Q33891605-BA70CF93-8B24-40A2-B79E-45C0A2DBA2BC Q34026267-A8FC0F86-95C5-46D7-A411-2D308B07FE27 Q34150935-75AA3063-D84D-495E-9010-D44E7A89A214 Q34237946-2EC600D1-603B-446E-9D36-B792674646A9 Q34355341-C951D32A-5CF6-4599-BD85-2A45814F635D Q34643153-B3F6716E-EDB2-4D18-858D-917616AEB414 Q34729487-A4DD5481-22D4-4C03-A970-3ACC1F75CCEA Q35065709-828E49C3-B627-489E-B87D-2DFBCF3109C4 Q35067093-9C91F06F-FAE3-4DDD-BAB0-3C52C1E1477A Q35201457-EBA585A6-A639-4CC7-AA43-7A2D127EBADA Q35280502-5387B5B4-C552-403D-B028-5104B99FE6B0 Q35598281-6F7384C4-B335-41D0-AE17-61361478C38C Q35732526-4E0B7637-41D8-4C1D-B265-50F1E0477804 Q35821475-6143BDE9-7A95-4388-8F09-28F52BC29F46 Q36148245-1948A793-2980-471B-BDCE-86D8224CAAD2 Q36156130-6E4DD2D2-1694-4DED-B74D-8F610D58E28B Q36548097-2024AB70-93B5-435B-A8F7-9E3574CFD38D Q36605876-606E4FC3-273F-4032-8F70-C530F948157E Q37335095-66BD750B-3DC1-446F-AF1E-46940F134951 Q37554055-992A551E-F071-4532-A687-4E25C0CD3D10 Q37713399-3A18007E-8E3D-4404-99BB-84CF689C6CC8 Q38131290-729FF080-B2ED-43E0-BE95-0565A494A0D7 Q38186068-DB74180F-7ABD-4702-8C3C-BDCD687E7F3F Q38266675-591AB607-942B-4D93-B54A-BC3F42D0A595 Q38526460-7B8EE637-CCD0-4C74-B3BC-76EB3ABC29B8 Q38626954-FFE8722C-DC1E-4AA6-AFD8-FED087CBAB71 Q38633105-04148639-D276-49ED-B00B-E39DB24066EA Q38672292-D80B5157-5A5A-445E-8D92-17CE3CAE312D

P2860

Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene

http://www.wikidata.org/entity/Q34045325

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@ast

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@en

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@nl

type

label

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@ast

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@en

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@nl

prefLabel

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@ast

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@en

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@nl

P1433

Q34045325-C5204EF3-CC08-4A48-A368-E2CA7D6C0B88

P1476

Q34045325-59E85F3E-9E20-4BF5-A836-127D75D17CD7

P2093

Q34045325-A47D23FF-EF1C-49E1-BC2C-7E9EA9793EDE

Q34045325-AAE2A2C0-2C1D-4A0B-B351-ED76AF2D8268

Q34045325-E5A79ADB-6878-43AC-93BD-4A54D5806D02

P2860

Q34045325-0A651321-1897-4BBA-B3B1-10BD9207751A

Q34045325-2A978624-0E39-43C7-8C9B-958C71697318

Q34045325-2C94FC37-3487-4929-8B5D-4EB109D11BCA

Q34045325-2D1D192D-AB1F-4A46-9F4F-4ACD1B5AAA1A

Q34045325-327C6476-EDEE-4B41-A0E6-3F14B84B67B1

Q34045325-391DF5DE-BE9D-405C-9728-DF13A02109CC

Q34045325-4D4CA6EB-F717-49F5-9A08-51F6CDA4F3BA

Q34045325-6AAA88B3-DB06-42F6-AB15-C047ED6ABA92

Q34045325-71BD7A96-3A38-4FB7-A63E-EE1426E3EFCD

Q34045325-770D8BD2-E31B-4319-AF3B-16E2CC84FD1E

P304

Q34045325-FEA19C28-009B-40FF-89A1-6F7FCD927087

P31

Q34045325-1A908AD2-7991-406F-B759-962FEC730595

P356

Q34045325-73B15AA1-5EFE-45DA-A788-B1714609E45C

P407

Q34045325-BF16ABE5-6BFC-4964-B599-7EDC6A9E1A25

P433

Q34045325-A49595E3-D2F0-40DB-8DAC-5A35254EA466

P478

Q34045325-16D62484-B98B-4409-8333-6BCC8CEABCEE

P50

Q34045325-92F9F508-BD38-44A0-A566-69B980546BD9

P577

Q34045325-8100649B-0DD0-48DD-8F18-240B9166E4AD

P698

Q34045325-680843D0-4935-420C-8E58-21257E0B2817

P921

Q34045325-20C2E32F-C10B-490B-96A8-AB7BBC3D5B17

P932

Q34045325-CDA56AFF-08E1-4A12-BD91-32F905916D31

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Role of Fks1p and matrix gluca ...... andin, pyrimidine, and polyene

@en

P2093

Jeniel E Nett

http://www.w3.org/2001/XMLSchema#string

Karen Marchillo

http://www.w3.org/2001/XMLSchema#string

Kyler Crawford

http://www.w3.org/2001/XMLSchema#string

P2860

A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

Candida biofilms: antifungal resistance and emerging therapeutic options.

Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan.

RIM101-dependent and-independent pathways govern pH responses in Candida albicans.

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Biofilm formation: a clinically relevant microbiological process.

Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.

Candida biofilms and their role in infection.

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.

P304

3505-3508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00227-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20516280

http://www.w3.org/2001/XMLSchema#string

P921

P932

2916329

http://www.w3.org/2001/XMLSchema#string